NERV
#3529
Minerva Neurosciences, Inc - Common Stock
4.8 4 USD
-0.06%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-5.65%
Changement Mensuel
+17.48%
Evolution sur 6 mois
-24.61%
Changement Annuel
+105.96%
Clôture Précédente
5.1 3
Open
4.8 4
Low
4.8 4
High
4.8 4
Volume
37
Financials
- Market Capitalization 231.1 M
- Employee 7
- Founded 2007
- CEO N/A
- Website www.minervaneurosciences.com
- Headquarter Massachusetts, United States
- FIGI BBG0067S9Z73
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.12
ratio cours/chiffre d'affaires
-601.6
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3517 |  RNA Atrium Therapeutics, Inc. - Common Stock | 13.64 USD | -2.43% | +2.79% | +20.39% | -80.61% | 233.32 M USD | ||
| 3519 |  TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | 13.59 USD | +0.22% | +5.43% | +44.11% | -9.46% | 233.08 M USD | ||
| 3535 |  GLSI Greenwich LifeSciences, Inc. - Common stock | 15.67 USD | -16.34% | -5.83% | +20.82% | +35.09% | 230.01 M USD | ||
| 3545 |  TARA Protara Therapeutics, Inc. - Common Stock | 3.82 USD | -4.26% | +1.60% | +0.53% | +22.04% | 225.74 M USD |